Padma Biotech And Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 23 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -15.22%
- Profit Growth -77.20%
- Ebitda -67.57%
- Net Worth 2.18%
- Total Assets -2.59%
About Padma Biotech And Healthcare
Padma Biotech And Healthcare Private Limited (PBAHPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 October 2001 and has a history of 23 years and three months. Its registered office is in Delhi, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Jain and Sunil Kumar serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51397DL2001PTC112718
-
Company No.
112718
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Oct 2001
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Padma Biotech And Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Jain
|
Director | 08-Oct-2001 | Current |
|
Sunil Kumar
|
Director | 08-Oct-2001 | Current |
Financial Performance of Padma Biotech And Healthcare.
Padma Biotech And Healthcare Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 15.22% decrease. The company also saw a substantial fall in profitability, with a 77.2% decrease in profit. The company's net worth moved up by a moderate rise of 2.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Padma Biotech And Healthcare?
In 2020, Padma Biotech And Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Resource E Waste Solutions Private LimitedSanjay Jain is a mutual person
-
Resource Waste Managers LlpSanjay Jain is a mutual person
-
Recyclekart Technologies Private Limited
Sanjay Jain is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Padma Biotech And Healthcare?
Unlock and access historical data on people associated with Padma Biotech And Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Padma Biotech And Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Padma Biotech And Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
